Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban

BACKGROUND: Reducing major bleeding events is a challenge when managing anticoagulation in patients with atrial fibrillation. This study evaluated the impact of modifiable and nonmodifiable bleeding risk factors in patients with atrial fibrillation receiving rivaroxaban and estimated the impact of r...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirchhof, Paulus, Haas, Sylvia, Amarenco, Pierre, Hess, Susanne, Lambelet, Marc, van Eickels, Martin, Turpie, Alexander G. G., Camm, A. John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335544/
https://www.ncbi.nlm.nih.gov/pubmed/32079476
http://dx.doi.org/10.1161/JAHA.118.009530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335544/
https://www.ncbi.nlm.nih.gov/pubmed/32079476
http://dx.doi.org/10.1161/JAHA.118.009530

Ejemplares similares